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Abstract 
 
To determine the effect on cognitive functioning of discontinuation of GH treatment from 
GH-treated adults with GH deficiency (GHD), GH replacement was discontinued for 3 
months from 12 of 21 adults, in a double-blind placebo-controlled trial, where 9 continued 
with GH. The following cognitive tests were given at baseline and end-point: Warrington 
Visual Recognition Memory, Benton Visual Retention, Rey Auditory Verbal Learning, Trail 
Making, Controlled Oral Word Association, Digit Span and Graded Naming. (Tests were 
split if no alternative available for end-point testing). Semi-structured interviews and 
questionnaires also given. Ethical Committee approval was obtained.  
  
Results: The cognitive tests found no significant change in cognitive functioning (nor any 
trends in data) in either treatment group relative to baseline, and no significant between-
group differences in scores at end-point when baseline scores had been partialed out. 
However, in interviews, 3 placebo-treated and 2 GH-treated patients reported perceived 
worsening of memory and concentration over the withdrawal period. Four of these patients 
also reported increased depression, confirmed in 3 cases by measures of psychological 
well-being.  
 
Conclusions: Some studies have reported negative effects of GHD on cognitive 
functioning, with improvements after GH-replacement therapy. In the present study 
cognitive tests found no detrimental effects on cognitive functioning after discontinuation of 
GH-treatment in GH-deficient adults.  Patient reports of perceived poorer cognitive 
functioning in relation to untreated GHD may be associated with increased depression.  
 
 
 
